LENZ
LENZ Therapeutics Inc
NASDAQ: LENZ · HEALTHCARE · BIOTECHNOLOGY
$8.98
-0.77% today
Updated 2026-04-30
Market cap
$306.02M
P/E ratio
—
P/S ratio
16.03x
EPS (TTM)
$-2.85
Dividend yield
—
52W range
$8 – $50
Volume
0.9M
LENZ Therapeutics Inc (LENZ) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-19000.00 | $-8.72M | $-52.85M | $-87.98M | $-60.38M | $-59.39M | $-69.17M |
| Capital expenditures | $0.00 | $1.54M | $5.74M | $6.59M | $30000.00 | $468000.00 | $827000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $196000.00 | $721000.00 | $1.34M | $6.37M | $12.55M |
| Free cash flow | $-19000.00 | $-10.27M | $-58.59M | $-94.57M | $-60.41M | $-59.86M | $-70.00M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |